Security key
293602504
Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC)
CUSIP: 293602504
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 140,823
- Total 13F value
- $1,145,879
- Share change
- +140,823
- SEC-reported price per share
- $8.14
- Number of holders
- 8
- Value change
- +$1,145,879
- Number of buys
- 8
- Shares outstanding
- 2,371,778
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
8
Top holders
8
ENSC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Ensysce Biosciences, Inc. SEC filings
Ensysce Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 293602504
Recent filing periods:
Ownership snapshot
Top reported holders of ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anson Funds Management LP
Disclosed value leader
A. Lorne Weil
Comparable rows
12/15
Latest evidence
30 Sep 2024
13F
13D/G
3/4/5
Lead comparable stake: 2.1%
3 rows are not safely comparable across share classes.
13D/G row: Anson Funds Management LP
Showing 1-6 of 15 holder rows.
Quick read
Anson Funds Management LP leads the comparable SEC ownership view at 2.1%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Anson Funds Management LP's linked filing trail.
Comparable ownership
Top 5
Anson Funds Management LP
2.1%
SABBY MANAGEMENT, LLC
5.9%
UBS Group AG
0.57%
GEODE CAPITAL MANAGEMENT, LLC
0.24%
CITADEL ADVISORS LLC
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anson Funds Management LP |
13F
13D/G
Company
|
2.1%
from 13D/G
|
$236,044
983,518 shares
|
— | 30 Sep 2024 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
5.9%
|
$279,022
1,162,592 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
0.57%
|
$27,044
112,682 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.24%
|
$11,057
46,072 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.12%
|
$5,665
23,605 shares
|
— | 30 Sep 2024 |
| HRT FINANCIAL LP |
13F
Company
|
0.12%
|
$5,000
23,558 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
140,823
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
15
Q4 2024 holders
8
Holder diff
-7
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend